MedTrace Logo

Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage

NCT01849549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2026-02-06

No results posted yet for this study

Summary

Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative disorders and selective cognitive disorders; (ii) healthy control subjects.

The objective of this project is to evaluate specific neuropsychological deficits and apply current brain imaging techniques (anatomical, diffusion, functional) to patients suffering from these cognitive deficits due to brain damage, in order to elucidate the brain mechanisms underlying these deficits.

Conditions

  • Cerebrovascular Disorders
  • Brain Lesions
  • Degenerative Diseases
  • Developmental Pathology

Interventions

BEHAVIORAL

Neuropsychological testing

Experimental test about cognitive deficit of interest and standard neuropsychological tests.

OTHER

MRI

Anatomical, diffusion, and/or functional MRI

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • David Wallon, Doctor · Neurology Department

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2022-03-01
Completion
2022-03-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01849549 on ClinicalTrials.gov